Detailed information for compound 34607

Basic information

Technical information
  • TDR Targets ID: 34607
  • Name: 3-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl ]-2,4-dihydropyrazolo[4,3-d]pyrimidine-7-thio ne
  • MW: 284.292 | Formula: C10H12N4O4S
  • H donors: 4 H acceptors: 6 LogP: -2.09 Rotable bonds: 2
    Rule of 5 violations (Lipinski): 1
  • SMILES: OCC1OC(C(C1O)O)c1n[nH]c2c1ncnc2S
  • InChi: 1S/C10H12N4O4S/c15-1-3-7(16)8(17)9(18-3)5-4-6(14-13-5)10(19)12-2-11-4/h2-3,7-9,15-17H,1H2,(H,13,14)(H,11,12,19)
  • InChiKey: LQKUBPCOEHEOEC-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

  • 3-[3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-2,4-dihydropyrazolo[4,3-d]pyrimidine-7-thione
  • 3-[3,4-dihydroxy-5-(hydroxymethyl)-2-tetrahydrofuranyl]-2,4-dihydropyrazolo[4,3-d]pyrimidine-7-thione
  • 3-(3,4-dihydroxy-5-methylol-tetrahydrofuran-2-yl)-2,4-dihydropyrazolo[4,3-d]pyrimidine-7-thione
  • 3-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-2,4-dihydropyrazolo[3,4-e]pyrimidine-7-thione
  • 3-[3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-2,4-dihydropyrazolo[3,4-e]pyrimidine-7-thione
  • 3-[3,4-dihydroxy-5-(hydroxymethyl)-2-tetrahydrofuranyl]-2,4-dihydropyrazolo[3,4-e]pyrimidine-7-thione
  • 3-(3,4-dihydroxy-5-methylol-tetrahydrofuran-2-yl)-2,4-dihydropyrazolo[3,4-e]pyrimidine-7-thione
  • 13263-91-7
  • 3-.beta.-d-Ribofuranosylpyrazolo[4,3-d]pyrimidin-7-thione
  • NSC122325

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Giardia lamblia DINP protein human, muc B family 0.0019 0.0228 1
Schistosoma mansoni cpg binding protein 0.0028 0.0369 0.0608
Echinococcus multilocularis dna polymerase eta 0.0019 0.0228 0.0303
Trypanosoma brucei DNA polymerase IV, putative 0.0019 0.0228 0.0644
Plasmodium vivax DNA repair protein REV1, putative 0.0006 0.0028 0.5
Trypanosoma cruzi 2,4-dihydroxyhept-2-ene-1,7-dioic acid aldolase, putative 0.0024 0.0306 0.0895
Trypanosoma brucei DNA polymerase kappa, putative 0.0019 0.0228 0.0644
Plasmodium falciparum DNA repair protein REV1, putative 0.0006 0.0028 0.5
Schistosoma mansoni Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) 0.0049 0.0686 0.1129
Schistosoma mansoni DNA polymerase IV / kappa 0.0006 0.0028 0.0046
Echinococcus granulosus cpg binding protein 0.003 0.0394 0.0578
Trypanosoma brucei DNA polymerase kappa, putative 0.0019 0.0228 0.0644
Echinococcus granulosus citrate lyase subunit beta protein 0.0024 0.0306 0.0432
Trypanosoma cruzi DNA polymerase kappa, putative 0.0019 0.0228 0.0644
Trichomonas vaginalis Citrate lyase beta chain, putative 0.0024 0.0306 1
Trypanosoma cruzi DNA polymerase kappa, putative 0.0019 0.0228 0.0644
Trypanosoma brucei DNA polymerase kappa, putative 0.0013 0.0138 0.0354
Echinococcus multilocularis histone lysine N methyltransferase MLL3 0.0009 0.0072 0.0044
Schistosoma mansoni mixed-lineage leukemia protein mll 0.006 0.0852 0.1403
Schistosoma mansoni terminal deoxycytidyl transferase 0.0019 0.0228 0.0375
Echinococcus granulosus dnaJ subfamily B 0.04 0.6075 1
Echinococcus granulosus dna polymerase kappa 0.0019 0.0228 0.0303
Trypanosoma brucei unspecified product 0.0019 0.0228 0.0644
Schistosoma mansoni mixed-lineage leukemia protein mll 0.0007 0.0045 0.0074
Mycobacterium ulcerans citrate lyase beta subunit, CitE_2 0.0024 0.0306 1
Trypanosoma cruzi DNA polymerase kappa, putative 0.0019 0.0228 0.0644
Leishmania major DNA polymerase kappa, putative 0.0019 0.0228 0.0644
Leishmania major DNA polymerase kappa, putative,DNA polymerase IV, putative 0.0019 0.0228 0.0644
Toxoplasma gondii histone lysine methyltransferase SET1 0.0053 0.0754 0.0728
Echinococcus granulosus terminal deoxycytidyl transferase rev1 0.0019 0.0228 0.0303
Loa Loa (eye worm) GTP-binding regulatory protein Gs alpha-S chain 0.0049 0.0686 0.066
Schistosoma mansoni cpg binding protein 0.003 0.0394 0.0648
Trypanosoma brucei hypothetical protein, conserved 0.0208 0.313 1
Trypanosoma brucei DNA polymerase kappa, putative 0.0019 0.0228 0.0644
Trypanosoma brucei DNA polymerase kappa, putative 0.0019 0.0228 0.0644
Leishmania major DNA polymerase eta, putative 0.0019 0.0228 0.0644
Brugia malayi ImpB/MucB/SamB family protein 0.0019 0.0228 0.3035
Trypanosoma cruzi 2,4-dihydroxyhept-2-ene-1,7-dioic acid aldolase, putative 0.0024 0.0306 0.0895
Schistosoma mansoni Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) 0.0049 0.0686 0.1129
Echinococcus multilocularis guanine nucleotide binding protein G(s) subunit 0.0049 0.0686 0.1063
Brugia malayi CXXC zinc finger family protein 0.0028 0.0369 0.5183
Mycobacterium ulcerans citrate (pro-3S)-lyase subunit beta 0.0024 0.0306 1
Mycobacterium ulcerans DNA polymerase IV 0.0019 0.0228 0.7191
Echinococcus granulosus dna polymerase eta 0.0019 0.0228 0.0303
Trypanosoma brucei DNA polymerase kappa, putative 0.0019 0.0228 0.0644
Toxoplasma gondii hypothetical protein 0.0656 1 1
Leishmania major 2,4-dihydroxyhept-2-ene-1,7-dioic acid aldolase, putative 0.0024 0.0306 0.0895
Trypanosoma brucei DNA polymerase IV, putative 0.0019 0.0228 0.0644
Trichomonas vaginalis DNA polymerase IV / kappa, putative 0.0019 0.0228 0.711
Schistosoma mansoni DNA polymerase eta 0.0019 0.0228 0.0375
Mycobacterium ulcerans citrate (pro-3S)-lyase subunit beta 0.0024 0.0306 1
Trypanosoma brucei DNA polymerase kappa, putative 0.0013 0.0138 0.0354
Trypanosoma brucei DNA polymerase kappa, putative 0.0019 0.0228 0.0644
Brugia malayi GTP-binding regulatory protein Gs alpha-S chain, putative 0.0049 0.0686 1
Loa Loa (eye worm) histone methyltransferase 0.0009 0.0072 0.0044
Schistosoma mansoni rab geranylgeranyl transferase alpha subunit 0.0019 0.0228 0.0375
Echinococcus multilocularis guanine nucleotide binding protein G(s) subunit 0.0049 0.0686 0.1063
Trypanosoma cruzi hypothetical protein, conserved 0.0208 0.313 1
Onchocerca volvulus 0.0028 0.0369 0.5
Loa Loa (eye worm) hypothetical protein 0.0019 0.0228 0.02
Echinococcus granulosus histone lysine N methyltransferase MLL3 0.0009 0.0072 0.0044
Schistosoma mansoni cpg binding protein 0.003 0.0394 0.0648
Echinococcus multilocularis dnaJ subfamily B 0.04 0.6075 1
Mycobacterium ulcerans DNA polymerase IV 0.0019 0.0228 0.7191
Schistosoma mansoni Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) 0.0049 0.0686 0.1129
Trypanosoma brucei DNA polymerase kappa, putative 0.0019 0.0228 0.0644
Echinococcus multilocularis terminal deoxycytidyl transferase rev1 0.0019 0.0228 0.0303
Echinococcus multilocularis dna polymerase kappa 0.0019 0.0228 0.0303
Mycobacterium tuberculosis Probable citrate (pro-3S)-lyase (beta subunit) CitE (citrase) (citratase) (citritase) (citridesmolase) (citrase aldolase) 0.0024 0.0306 1
Brugia malayi ImpB/MucB/SamB family protein 0.0019 0.0228 0.3035
Trypanosoma brucei DNA polymerase kappa, putative 0.0019 0.0228 0.0644
Loa Loa (eye worm) inward rectifying k channel family protein 1 0.0656 1 1
Trypanosoma cruzi DNA polymerase kappa, putative 0.0019 0.0228 0.0644
Trypanosoma brucei DNA polymerase kappa, putative 0.0019 0.0228 0.0644
Leishmania major hypothetical protein, conserved 0.0208 0.313 1
Loa Loa (eye worm) hypothetical protein 0.0656 1 1
Loa Loa (eye worm) CXXC zinc finger family protein 0.0028 0.0369 0.0342
Echinococcus granulosus guanine nucleotide binding protein Gs subunit 0.0049 0.0686 0.1063
Trichomonas vaginalis DNA polymerase eta, putative 0.0019 0.0228 0.711
Trypanosoma cruzi hypothetical protein, conserved 0.0208 0.313 1
Echinococcus granulosus guanine nucleotide binding protein Gs subunit 0.0049 0.0686 0.1063
Trypanosoma cruzi DNA polymerase eta, putative 0.0019 0.0228 0.0644
Mycobacterium ulcerans hypothetical protein 0.0024 0.0306 1
Trypanosoma brucei unspecified product 0.0013 0.0138 0.0354
Brugia malayi F/Y-rich N-terminus family protein 0.0009 0.007 0.0634
Entamoeba histolytica deoxycytidyl transferase, putative 0.0019 0.0228 0.5
Mycobacterium ulcerans hypothetical protein 0.0024 0.0306 1
Schistosoma mansoni hypothetical protein 0.04 0.6075 1
Trypanosoma brucei DNA polymerase IV, putative 0.0019 0.0228 0.0644
Loa Loa (eye worm) ImpB/MucB/SamB family protein 0.0019 0.0228 0.02
Loa Loa (eye worm) hypothetical protein 0.0656 1 1
Trypanosoma brucei unspecified product 0.0013 0.0138 0.0354
Mycobacterium tuberculosis Conserved protein 0.0024 0.0306 1
Echinococcus multilocularis cpg binding protein 0.003 0.0394 0.0578
Echinococcus multilocularis citrate lyase subunit beta protein 0.0024 0.0306 0.0432
Trypanosoma brucei DNA polymerase kappa, putative 0.0013 0.0138 0.0354
Trypanosoma brucei DNA polymerase kappa, putative 0.0019 0.0228 0.0644
Trypanosoma brucei DNA polymerase eta, putative 0.0019 0.0228 0.0644

Activities

Activity type Activity value Assay description Source Reference
Plaque reduction (functional) = 0 % Percentage plaque reduction was determined against venezuelan equine encephalitis(VEE) virus in african green monkey kidney (vero,V) at a conc of 250-500 microg/mL. Toxic level(1000 microg/mL) ChEMBL. 7143371
Plaque reduction (functional) = 0 % Percentage plaque reduction was determined against venezuelan equine encephalitis(VEE) virus in african green monkey kidney (vero,V) at a conc of 100-250 microg/mL. Toxic level(1000 microg/mL) ChEMBL. 7143371
Plaque reduction (functional) = 0 % Percentage plaque reduction was determined against venezuelan equine encephalitis(VEE) virus in african green monkey kidney (vero,V) at a conc of 25-100 microg/mL. Toxic level(1000 microg/mL) ChEMBL. 7143371
Plaque reduction (functional) = 0 % Percentage plaque reduction was determined against venezuelan equine encephalitis(VEE) virus in african green monkey kidney (vero,V) at a conc of <25 microg/mL. Toxic level(1000 microg/mL) ChEMBL. 7143371
Plaque reduction (functional) = 10 % Percentage plaque reduction was determined against rift valley fever(RVF) virus in african green monkey kidney (vero,V) at a conc of 250-500 microg/mL. Toxic level(1000 microg/mL); 10-30 ChEMBL. 7143371
Plaque reduction (functional) = 10 % Percentage plaque reduction was determined against pichinde(PICH) virus in african green monkey kidney (vero,V).Toxic level(1000 microg/mL); 10-30 ChEMBL. 7143371
Plaque reduction (functional) = 61 % Percentage plaque reduction was determined against yellow fever(YF) virus in african green monkey kidney (vero,V).Toxic level(1000 microg/mL); 61-90 ChEMBL. 7143371
Plaque reduction (functional) = 61 % Percentage plaque reduction was determined against Sandfly fever (SF) virus in african green monkey kidney (vero,V) at a conc of 25-100 microg/mL. Toxic level(1000 microg/mL); 61-90 ChEMBL. 7143371
Virus rating (functional) = 0 In vitro antiviral activity against herpes simplex type 1 (HSV-1) virus was determined in african green monkey kidney (vero,V) expressed as virus rating. Toxic level(1000 microg/mL) ChEMBL. 7143371
Virus rating (functional) = 1 In vitro antiviral activity against vaccinia(VV) virus was determined in african green monkey kidney (vero,V) expressed as virus rating. Toxic level(1000 microg/mL) ChEMBL. 7143371
Virus rating (functional) = 1.1 In vitro antiviral activity against parainfluenza type 3(para 3) virus was determined in african green monkey kidney (vero,V) expressed as virus rating. Toxic level(1000 microg/mL) ChEMBL. 7143371

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.